Migraine is a disabling condition that affects an estimated 85 million people in worldwide. The U.S. Food and Drug Administration, recently, approved a new drug for the acute treatment of migraines with or without aura in adults. The drug is the first of its kind and has been deemed safe and effective to use after promising results from a clinical trial. Introduction: Migraine headache pain is defined as an intense throbbing or pulsating pain in one area of the head.
Symptoms include nausea and/or vomiting and sensitivity to light and sound. Approximately one-third of individuals with migraine also experience an aura before the migraine. Migraines can be triggered by factors like hormone changes, stress, bright or flashing lights, and lack of food or sleep. Migraine is three times more common in women than in men and affects more than 10% of people worldwide. Drug Profile Of Ubrogepant:…
